Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Japan's Takeda Pharmaceutical Co. Ltd. (TAK) announced Monday that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE)1 It will be available in 2 mg/10 mL convenient, single-dose stick packs by the end of February.

RTTNews | 546 days ago

Takeda Says Japan Approves CUVITRU Subcutaneous Immunoglobulin For Patients With Agammaglobulinemia

Takeda Pharmaceutical Co. Ltd. (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] in patients aged 2 years and older with agammaglobulinemia or hypogammaglobulinemia disorders.

RTTNews | 686 days ago

Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD) after induction therapy with ENTYVIO intravenous (IV).

RTTNews | 698 days ago

Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis

Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.

RTTNews | 700 days ago

Rate Cut Hopes Drag The Dollar Down

The U.S. dollar declined against major currencies during the week ended August 8 amidst weak economic data that renewed hopes of a larger-than expected and higher-than-expected monetary policy easing by the Federal Reserve.

RTTNews | 2h 17min ago

Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Canadian stocks may open with a slightly positive bias on Monday with investors looking ahead to the crucial U.S. inflation data due this week. The focus is also Trump administration's trade negotiations with China, and on the upcoming talks between the U.S. and Russia, aimed at bringing an end to the war in Ukraine.

RTTNews | 4h 30min ago

FTSE 100 Up Marginally As Investors Look For Direction

The U.K. market is up in positive territory a little before noon on Monday with select counters attracting some strong buying interest. Uncertainty on the tariff front is rendering the mood a bit cautious and limiting the market's upside.

RTTNews | 6h 5min ago

CAC 40 Drifts Lower In Lackluster Trade

French stocks are down in negative territory on Monday as investors look for direction and make cautious moves while awaiting U.S. - Russia talks set to take place later in the week.

RTTNews | 6h 25min ago

EURUSD	1.16073	GBPUSD	1.34233	AUDUSD	0.65122
USDJPY	147.997	USDCAD	1.37839	USDCHF	0.81271